CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MarxBio is developing a diagnostic kit to detect Graft versus Host Disease using a blood test linked to the enzyme GSK-3beta. This innovative approach aims to provide timely diagnosis and monitoring of the disease, potentially improving treatment outcomes for patients undergoing transplants.
Transplantations are life-saving treatments, often representing the only option for people with severe disease such as bloodcancers.
Unfortunately, complications linked to transplants are so high that they are current limiting the increase of adoptionof transplantations.
Specifically, Graft versus Host Disease occurs in up to 80% cases after receiving bone marrow from adonour and poses a serious threat to the life of patients already in critical condition.
Graft versus Host Disease, today, canon…
MARX BIOTECHNOLOGY LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
